Stelvio Therapeutics Company

Stelvio Oncology is developing a personalized approach to glioblastoma treatment. Their team has core competencies of scientific creativity, clinical excellence and professional management required to successfully commercialize novel drug therapies and precision medicine diagnostics.
Technology: Personalised Medicine
Industry: Early Drug Development
Headquarters: San Diego, California, United States
Founded Date: 2017-03-01
Employees Number: 11-50
Funding Status: Seed
Investors Number: 2
Estimated Revenue: Less than $1M
Last Funding Date: 2017-05-05
Last Funding Type: Seed

Visit Website
https://twitter.com/StelvioOncology
Register and Claim Ownership